Caveolin 1 inhibits transforming growth factor-β1 activity via inhibition of Smad signaling by hypertrophic scar derived fibroblasts in vitro

Journal of Dermatological Science

Volumn 62, Issue 2, 2011, Pages 128-131

  Zhang, Guo You ^a,b   He, Bin ^c   Liao, Tian ^d   Luan, Qi ^e   Tao, Cheng ^f   Nie, Chun Lei ^g   Albers, Andreas E ^d   Zheng, Xin ^d   Xie, Xue guan ^a   Gao, Wei Yang ^a  

^a THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF LÜBECK   (Germany)

^c THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^f SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^g HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CAVEOLIN 1; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FIBROBLAST CULTURE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERTROPHIC SCAR; IN VITRO STUDY; LETTER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SCAR FORMATION; SIGNAL TRANSDUCTION; UPREGULATION;

ADOLESCENT; ADULT; CAVEOLIN 1; CICATRIX, HYPERTROPHIC; CULTURE MEDIA, SERUM-FREE; DNA PRIMERS; FEMALE; FIBROBLASTS; HUMANS; MALE; PEPTIDES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79954614829     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.10.018     Document Type: Letter

References (10)

1. Guoyou Z., Chenggang Y., Chengyue M., Xuan L., Yan Z., Wei X., et al. Modulation of transforming growth factor-beta1 production by vector-based RNAi in hypertrophic scar fibroblasts: a therapeutic potential strategy for hypertrophic scar. J Dermatol Sci 2007, 48:67-70.
2. Lee E.K., Lee Y.S., Han I.O., Park S.H. Expression of caveolin-1 reduces cellular responses to TGF-beta1 through down-regulating the expression of TGF-beta type II receptor gene in NIH3T3 fibroblast cells. Biochem Biophys Res Commun 2007, 359:385-390.
3. Razani B., Zhang X.L., Bitzer M., von Gersdorff G., Böttinger E.P., Lisanti M.P. Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. J Biol Chem 2001, 276:6727-6738.
4. Zhang X.L., Topley N., Ito T., Phillips A. Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling. J Biol Chem 2005, 280:12239-12245.
5. Wang X.M., Zhang Y., Kim H.P., Zhou Z., Feghali-Bostwick C.A., Liu F., et al. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med 2006, 203:2895-2906.
6. Del Galdo F., Sotgia F., de Almeida C.J., Jasmin J.F., Musick M., Lisanti M.P., Jiménez S.A., et al. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis. Arthritis Rheum 2008, 58:2854-2865.
7. Tourkina E., Richard M., Gööz P., Bonner M., Pannu J., Harley R., et al. Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 2008, 294:L843-L861.
8. Bernatchez P.N., Bauer P.M., Yu J., Prendergast J.S., He P., Sessa W.C. Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides. Proc Natl Acad Sci U S A 2005, 102:761-766.
9. Zhang G.Y., Yi C.G., Li X., Ma B., Li Z.J., Chen X.L., et al. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts. Br J Dermatol 2009, 160(4):762-770.
10. Border W.A., Noble N.A. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994, 331:12861292.